A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma
Clinical trial NCT04822805 · UNKNOWN
Trial details
- NCT number
- NCT04822805
- Sponsor
- First People's Hospital of Hangzhou
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-13
- Primary completion
- 2022-10-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.